World's Best Scientists 2026 revealed!
Award Badge
Best Female Scientists
2025
Award Badge
Immunology
USA
2026

D-Index & Metrics

Best Female Scientists

D-Index
165
Citations
124771
World Ranking
77
National Ranking
44

Best Scientists

D-Index
165
Citations
124771
World Ranking
1029
National Ranking
609

Immunology

D-Index
169
Citations
132866
World Ranking
57
National Ranking
40

Medicine

D-Index
169
Citations
132925
World Ranking
534
National Ranking
314

Arlene H. Sharpe publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Arlene H. Sharpe sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 521 publications — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Arlene H. Sharpe D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Arlene H. Sharpe sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 169 D-Index — 99th percentile

99% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Immunology in United States Leader Award
  • 2025 - Research.com Best Female Scientists Award
  • 2025 - Research.com Immunology in United States Leader Award
  • 2020 - Fellow, National Academy of Inventors
  • 2018 - Member of the National Academy of Medicine (NAM)
  • 2018 - Member of the National Academy of Sciences
  • 2017 - Warren Alpert Foundation Prize For their collective contributions to the pre-clinical foundation and development of immune checkpoint blockade, a novel form of cancer therapy that has transformed the landscape of cancer treatment.
  • 2006 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Arlene H. Sharpe is affiliated with Harvard University in the United States and has contributed extensively to the fields of medicine and immunology. Their research primarily focuses on immunology, oncology, molecular biology, genetics, and cancer research, with a significant emphasis on cancer immunotherapy and immune cell function. The body of work includes investigations into cancer immunotherapy and biomarkers, immune cell function and interaction, CAR-T cell therapy research, T-cell and B-cell immunology, immune cells in cancer, immunotherapy and immune responses, and glioma diagnosis and treatment.

Their recent publications include:

  • Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma (2020, Nature Medicine)
  • Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity (2020, Cell)
  • Spatially organized multicellular immune hubs in human colorectal cancer (2021, Cell)
  • Progressive immune dysfunction with advancing disease stage in renal cell carcinoma (2021, Cancer Cell)
  • The aging lung: Physiology, disease, and immunity (2021, Cell)

Frequent co-authors in their work include:

  • Gordon J. Freeman
  • Martin W. LaFleur
  • Kelly P. Burke
  • Marcia C. Haigis
  • Kristen E. Pauken

Sharpe's work has been published in a variety of scientific journals, with a notable presence in:

  • Cancer Immunology Research
  • The Journal of Immunology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancer Research
  • The Journal of Experimental Medicine

They have received recognition from several scientific organizations, including election to the National Academy of Sciences and the National Academy of Medicine in 2018. Additional honors include being named a Fellow of the National Academy of Inventors in 2020 and a Fellow of the American Association for the Advancement of Science in 2006. In 2017, Sharpe was awarded the Warren Alpert Foundation Prize for contributions related to the development of immune checkpoint blockade as a cancer therapy.

Best Publications

  • PD-1 and its ligands in tolerance and immunity

    Mary E. Keir;Manish J. Butte;Gordon J. Freeman;Arlene H. Sharpe

  • Restoring function in exhausted CD8 T cells during chronic viral infection.

    Daniel L. Barber;E. John Wherry;David Masopust;Baogong Zhu

  • Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4

    E A Tivol;F Borriello;A N Schweitzer;W P Lynch

  • PD-L2 is a second ligand for PD-1 and inhibits T cell activation

    Yvette Latchman;Clive R. Wood;Tatyana Chernova;Divya Chaudhary

  • THE B7 FAMILY REVISITED

    Rebecca J. Greenwald;Gordon J. Freeman;Arlene H. Sharpe

  • The PD-1 pathway in tolerance and autoimmunity

    Loise M. Francisco;Peter T. Sage;Arlene H. Sharpe;Arlene H. Sharpe

  • p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development

    Annie Yang;Ronen Schweitzer;Deqin Sun;Mourad Kaghad

  • B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes.

    Benoît Salomon;Deborah J Lenschow;Lesley Rhee;Neda Ashourian

  • The B7–CD28 superfamily

    Arlene H Sharpe;Gordon J Freeman

  • PD-L1 regulates the development, maintenance, and function of induced regulatory T cells

    Loise Marie Francisco;Victor H. Salinas;Keturah Elise Brown;Vijay K. Vanguri;Vijay K. Vanguri

  • Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens

    Matthew M. Gubin;Xiuli Zhang;Heiko Schuster;Etienne Caron

  • Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses

    Manish J. Butte;Mary E. Keir;Theresa B. Phamduy;Arlene H. Sharpe

  • Defining CD8 + T cells that provide the proliferative burst after PD-1 therapy

    Se Jin Im;Masao Hashimoto;Michael Y Gerner;Michael Y Gerner;Junghwa Lee

  • Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade.

    Brian C. Miller;Debattama R. Sen;Debattama R. Sen;Rose Al Abosy;Rose Al Abosy;Kevin Bi;Kevin Bi

  • The diverse functions of the PD1 inhibitory pathway.

    Arlene H Sharpe;Kristen E Pauken

  • The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection

    Arlene H Sharpe;E John Wherry;Rafi Ahmed;Gordon J Freeman

  • Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis.

    Qing Wang;Terryl Stacy;Michael Binder;Miguel Marin-Padilla

  • Increased Energy Expenditure, Decreased Adiposity, and Tissue-Specific Insulin Sensitivity in Protein-Tyrosine Phosphatase 1B-Deficient Mice

    Lori D. Klaman;Olivier Boss;Odile D. Peroni;Jason K. Kim

  • Defining ‘T cell exhaustion’

    Christian U Blank;W Nicholas Haining;Werner Held;Patrick G Hogan;Patrick G Hogan

  • Tissue expression of PD-L1 mediates peripheral T cell tolerance

    Mary E. Keir;Spencer C. Liang;Indira Guleria;Yvette E. Latchman

  • The Ikaros gene is required for the development of all lymphoid lineages.

    Katia Georgopoulos;Michael Bigby;Jin-Hong Wang;Arpad Molnar

Frequent Co-Authors

Gordon J. Freeman
Gordon J. Freeman Harvard University
W. Nicholas Haining
W. Nicholas Haining Arsenal Biosciences (United States)
Vijay K. Kuchroo
Vijay K. Kuchroo Harvard University
Rafi Ahmed
Rafi Ahmed Emory University
Bruce R. Blazar
Bruce R. Blazar University of Minnesota
E. John Wherry
E. John Wherry University of Pennsylvania
Mohamed H. Sayegh
Mohamed H. Sayegh American University of Beirut
Bernard N. Fields
Bernard N. Fields Harvard University
Hideo Yagita
Hideo Yagita Juntendo University
Marcia C. Haigis
Marcia C. Haigis Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare fields can broaden career opportunities. Many students consider pursuing a nursing path, such as becoming a Nurse Practitioner. Some programs are known for being the easiest nurse practitioner program, offering a more accessible route for busy professionals.

Mental health is a crucial aspect connected to immunological disorders, prompting interest in Psychiatric Mental Health Nurse Practitioner (PMHNP) programs. When selecting a program, it’s important to look for options with strong clinical training. The pmhnp programs online with best clinical placement ensure hands-on experience, vital for career success.

Cost is also a significant factor for many students. Discovering affordable pmhnp programs can make advanced nursing education more attainable without sacrificing quality. This is particularly beneficial for those balancing work and study.

Advanced degrees, such as the Doctorate in Nursing Practice (DNP), often lead to higher earning potential. Understanding the doctorate in nursing salary can help candidates evaluate the return on investment for these programs across different states.

Best Scientists Citing Arlene H. Sharpe

Trending Scientists

Recently Published Articles